Immune cell subset counts associated with graft-versus-host disease

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 4, 2014, Pages 450-462

  Podgorny, Peter J ^a   Liu, Yiping ^a   Dharmani Khan, Poonam ^a   Pratt, Laura M ^a   Jamani, Kareem ^a   Luider, Joanne ^a   Auer Grzesiak, Iwona ^a   Mansoor, Adnan ^a   Williamson, Tyler S ^a   Ugarte Torres, Alejandra ^a   Hoegh Petersen, Mette ^a   Stewart, Douglas A ^a   Daly, Andrew ^a   Khan, Faisal M ^a   Russell, James A ^a   Storek, Jan ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

B lymphocytes; Dendritic cells; Graft versus host disease; Hematopoietic cell transplantation; NK cells; T lymphocytes

Indexed keywords

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MIDDLE AGED; MYELOID DENDRITIC CELL; NATURAL KILLER CELL; PLASMACYTOID DENDRITIC CELL; RELAPSE; TRANSPLANTATION; YOUNG ADULT;

B LYMPHOCYTES; DENDRITIC CELLS; GRAFT-VERSUS-HOST DISEASE; HEMATOPOIETIC CELL TRANSPLANTATION; NK CELLS; T LYMPHOCYTES;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84895780508     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.01.002     Document Type: Article

References (66)

1. Blazar B.R., Murphy W.J., Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 2012, 12:443-458.
2. Choi S.W., Levine J.E., Ferrara J.L. Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin North Am 2010, 30:75-101.
3. Heimfeld S., Gooley T., Flowers M., et al. Effect of peripheral blood stem cell graft composition on graft versus host diseases and mortality after allogeneic transplantation. Blood 2010, 116:676.
4. McIver Z.A., Melenhorst J.J., Grim A., et al. Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome. Biol Blood Marrow Transplant 2011, 17:1846-1854.
5. Yakoub-Agha I., Saule P., Depil S., et al. Ahigh proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy. Leukemia 2006, 20:1557-1565.
6. Shimabukuro-Vornhagen A., Hallek M.J., Storb R.F., von Bergwelt-Baildon M.S. The role of B cells in the pathogenesis of graft-versus-host disease. Blood 2009, 114:4919-4927.
7. Christopeit M., Schutte V., Theurich S., et al. Rituximab reduces the incidence of acute graft-versus-host disease. Blood 2009, 113:3130-3131.
8. Fraser A.R., Cook G., Franklin I.M., et al. Immature monocytes from G-CSF-mobilized peripheral blood stem cell collections carry surface-bound IL-10 and have the potential to modulate alloreactivity. JLeukoc Biol 2006, 80:862-869.
9. Chaidos A., Patterson S., Szydlo R., et al. Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Blood 2012, 119:5030-5036.
10. Novitzky N., Davison G.M., Hale G., Waldmann H. Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome. Transplantation 2002, 74:1551-1559.
11. Rajasekar R., Mathews V., Lakshmi K.M., et al. Plasmacytoid dendritic cell count on day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD. Biol Blood Marrow Transplant 2008, 14:344-350.
12. Watanabe N., Narita M., Furukawa T., et al. Kinetics of pDCs, mDCs, gammadeltaT cells and regulatory T cells in association with graft versus host disease after hematopoietic stem cell transplantation. Int JLab Hematol 2011, 33:378-390.
13. Rubio M.T., Moreira-Teixeira L., Bachy E., et al. Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival. Blood 2012, 120:2144-2154.
14. Russell J.A., Turner A.R., Larratt L., et al. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis. Biol Blood Marrow Transplant 2007, 13:299-306.
15. Russell J.A., Savoie M.L., Balogh A., et al. Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin. Biol Blood Marrow Transplant 2007, 13:814-821.
16. Ugarte-Torres A., Hoegh-Petersen M., Liu Y., et al. Donor serostatus has an impact on cytomegalovirus-specific immunity, cytomegaloviral disease incidence, and survival in seropositive hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 2011, 17:574-585.
17. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
18. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
19. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
20. Korngold R., Friedman T.M. Murine models of graft-vs-host disease and graft-vs-tumor effect. Thomas' Hematopoietic Cell Transplantation 2009, 176-187. Wiley-Blackwell, West Sussex, UK. F.R. Appelbaum, S.J. Forman, R.S. Negrin, K.G. Blume (Eds.).
21. Storek J., Joseph A., Dawson M.A., et al. Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation. Transplantation 2002, 73:1154-1158.
22. Castermans E., Hannon M., Dutrieux J., et al. Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age. Haematologica 2011, 96:298-306.
23. Clave E., Busson M., Douay C., et al. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation. Blood 2009, 113:6477-6484.
24. Gattinoni L., Lugli E., Ji Y., et al. Ahuman memory T cell subset with stem cell-like properties. Nat Med 2011, 17:1290-1297.
25. Lugli E., Gattinoni L., Roberto A., et al. Identification, isolation and invitro expansion of human and nonhuman primate T stem cell memory cells. Nat Protoc 2013, 8:33-42.
26. Zhang Y., Joe G., Hexner E., et al. Host-reactive CD8+ memory stem cells in graft-versus-host disease. Nat Med 2005, 11:1299-1305.
27. Xystrakis E., Bernard I., Dejean A.S., et al. Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RChigh but not the CD45RClow subset. Eur JImmunol 2004, 34:408-417.
28. Spickett G.P., Brandon M.R., Mason D.W., et al. MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen. JExp Med 1983, 158:795-810.
29. Chen B.J., Cui X., Sempowski G.D., et al. Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease. Blood 2004, 103:1534-1541.
30. Anderson B.E., McNiff J., Yan J., et al. Memory CD4+ T cells do not induce graft-versus-host disease. JClin Invest 2003, 112:101-108.
31. Zhang Y., Joe G., Zhu J., et al. Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity. Blood 2004, 103:3970-3978.
32. Zhang P., Wu J., Deoliveira D., et al. Allospecific CD4(+) effector memory T cells do not induce graft-versus-host disease in mice. Biol Blood Marrow Transplant 2012, 18:1488-1499.
33. Beilhack A., Schulz S., Baker J., et al. Invivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 2005, 106:1113-1122.
34. Moncrieffe H., Coles M., Stockinger B. The influence of CD4 T-cell subsets on control of CD4 T-cell-mediated graft-versus-host disease. Immunology 2008, 125:459-468.
35. Bleakley M., Otterud B.E., Richardt J.L., et al. Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by invitro stimulation of naive CD8+ T cells. Blood 2010, 115:4923-4933.
36. Lord J.D., Hackman R.C., Gooley T.A., et al. Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host disease. Biol Blood Marrow Transplant 2011, 17:486-496.
37. Clark F.J., Gregg R., Piper K., et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. Blood 2004, 103:2410-2416.
38. Meignin V., Peffault de Latour R., Zuber J., Regnault A., Mounier N., Lemaitre F., Dastot H., Itzykson R., Devergie A., Cumano A., Gluckman E., Janin A., Bandeira A., Socie G. Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation. Exp Hematol 2005, 33:894-900.
39. Miura Y., Thoburn C.J., Bright E.C., Phelps M.L., Shin T., Matsui E.C., Matsui W.H., Arai S., Fuchs E.J., Vogelsang G.B., Jones R.J., Hess A.D. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 2004, 104:2187-2193.
40. Rezvani K., Mielke S., Ahmadzadeh M., Kilical Y., Savani B.N., Zeilah J., Keyvanfar K., Montero A., Hensel N., Kurlander R., Barrett A.J. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 2006, 108:1291-1297.
41. Zhai Z., Sun Z., Li Q., Zhang A., Liu H., Xu J., Xu X., Geng L., Harris D., Hu S., Wang Y. Correlation of the CD4+CD25high T-regulatory cells in recipients and their corresponding donors to acute GVHD. Transpl Int 2007, 20:440-446.
42. Beres A.J., Haribhai D., Chadwick A.C., et al. CD8+ Foxp3+ regulatory Tcells are induced during graft-versus-host disease and mitigate disease severity. JImmunol 2012, 189:464-474.
43. Kim S.J., Won J.H. Bcell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy. Leuk Lymphoma 2012, 53:19-25.
44. Bouaziz J.D., Calbo S., Maho-Vaillant M., et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation invitro. Eur J Immunol 2010, 40:2686-2691.
45. Rowe V., Banovic T., MacDonald K.P., et al. Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation. Blood 2006, 108:2485-2492.
46. Wong S.C., Puaux A.L., Chittezhath M., et al. Macrophage polarization to a unique phenotype driven by B cells. Eur J Immunol 2010, 40:2296-2307.
47. Le Huu D., Matsushita T., Jin G., et al. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. Blood 2013, 121:3274-3283.
48. van de Veen W., Stanic B., Yaman G., et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. JAllergy Clin Immunol 2013, 131:1204-1212.
49. Goetz M., Atreya R., Ghalibafian M., et al. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis 2007, 13:1365-1368.
50. Dass S., Vital E.M., Emery P. Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum 2007, 56:2715-2718.
51. Said E.A., Dupuy F.P., Trautmann L., et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med 2010, 16:452-459.
52. Gama L., Shirk E.N., Russell J.N., et al. Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection. JLeukoc Biol 2012, 91:803-816.
53. Walter G.J., Evans H.G., Menon B., et al. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells. Arthritis Rheum 2013, 65:627-638.
54. Geissmann F., Auffray C., Palframan R., et al. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol 2008, 86:398-408.
55. Storek J., Wells D., Dawson M.A., et al. Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. Blood 2001, 98:489-491.
56. Capitini C.M., Nasholm N.M., Duncan B.B., Guimond M., Fry T.J. Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis. J Immunol 2013, 190:1351-1359.
57. Shono Y., Ueha S., Wang Y., et al. Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation. Blood 2010, 115:5401-5411.
58. Garcia-Penarrubia P., Koster F.T., Kelley R.O., et al. Antibacterial activity of human natural killer cells. JExp Med 1989, 169:99-113.
59. Walzer T., Dalod M., Vivier E., Zitvogel L. Natural killer cell-dendritic cell crosstalk in the initiation of immune responses. Expert Opin Biol Ther 2005, 5(Suppl 1):S49-S59.
60. Serbina N.V., Jia T., Hohl T.M., Pamer E.G. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008, 26:421-452.
61. Sundquist M., Johansson C., Wick M.J. Dendritic cells as inducers of antimicrobial immunity invivo. APMIS 2003, 111:715-724.
62. Sokol C.L., Medzhitov R. Emerging functions of basophils in protective and allergic immune responses. Mucosal Immunol 2010, 3:129-137.
63. Perez-Martinez A., Iyengar R., Gan K., et al. Blood dendritic cells suppress NK cell function and increase the risk of leukemia relapse after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011, 17:598-607.
64. Rajasekar R., Lakshmi K.M., George B., et al. Dendritic cell count in the graft predicts relapse in patients with hematologic malignancies undergoing an HLA-matched related allogeneic peripheral blood stem cell transplant. Biol Blood Marrow Transplant 2010, 16:854-860.
65. Podgorny P.J., Ugarte-Torres A., Liu Y., et al. High rabbit-antihuman thymocyte globulin levels are associated with low likelihood of graft-vs-host disease and high likelihood of posttransplant lymphoproliferative disorder. Biol Blood Marrow Transplant 2010, 16:915-926.
66. Hoegh-Petersen M., Amin M.A., Liu Y., et al. Anti-thymocyte globulins capable of binding to T and B cells reduce graft-vs-host disease without increasing relapse. Bone Marrow Transplant 2013, 48:105-114.